The extracellular matrix market is projected to reach US$ 52.72 million by 2028 from US$ 31.49 million in 2021. It is estimated to grow at a CAGR of 7.6% from 2021 to 2028.
The extracellular matrix is present in the outer side of the tissues, and it helps tissues bind the cells with collagen. It consists of structural proteins, glycoproteins, glycosaminoglycans, and proteoglycans. Extracellular matrix enables recipient cells to regrow, and thus, it is used in various applications, including cardiac and vascular repair procedures. Several factors, such as the significant rising incidence of cardiovascular diseases and trauma and an increase in vascular reconstruction procedures, are boosting the extracellular matrix market growth. However, the challenges during the usage of decellularized extracellular matrix hamper the market's growth.
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Extracellular Matrix Market: Strategic Insights
Market Size Value in US$ 31.49 million in 2021 Market Size Value by US$ 52.72 million by 2028 Growth rate CAGR of 7.6% from 2021 to 2028. Forecast Period 2021-2028 Base Year 2021
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Customize Research To Suit Your Requirement
We can optimize and tailor the analysis and scope which is unmet through our standard offerings. This flexibility will help you gain the exact information needed for your business planning and decision making.
Extracellular Matrix Market: Strategic Insights
| Market Size Value in | US$ 31.49 million in 2021 |
| Market Size Value by | US$ 52.72 million by 2028 |
| Growth rate | CAGR of 7.6% from 2021 to 2028. |
| Forecast Period | 2021-2028 |
| Base Year | 2021 |
Mrinal
Have a question?
Mrinal will walk you through a 15-minute call to present the report’s content and answer all queries if you have any.
Speak to Analyst
Market Insights
Rising Incidences of Cardiovascular Disorders and Trauma Boosts Extracellular Matrix Market Growth
The significant rise in the cases of orthopedic trauma conditions and cardiovascular diseases is the leading factor behind the growth of the global extracellular matrix market. As a part of the treatment, the extracellular matrix offers several benefits in treating different chronic injuries caused due to surgery, accidents, chronic diseases, and other incidents. Moreover, heart failure and myocardial infarction incidences are increasing among the aging population. The minimally invasive treatment for these cardiovascular treatments procedures requires an extracellular matrix. A patient suffering from heart disease fails to restore the functional properties of cardiac tissue. The extracellular matrix's ability to regrow and promote adaptive repair and regeneration enables patients to recover their normal functions. Also, it has shown promising clinical outcomes for tissue engineering in the treatment of cardiovascular diseases and other health conditions.
Furthermore, the rising incidences of cardiovascular diseases are expected to drive the growth of the extracellular matrix. For instance, according to WHO data published in 2019, an estimated 17.9 million people died from CVDs 2019, representing 32% of all global deaths. Of these deaths, 85% were due to heart attack and stroke. According to the European Cardiovascular Disease Statistics report of 2017, in Europe, each year cardiovascular disease (CVD) causes 3.9 million deaths and over 1.8 million deaths in the European Union (EU).
Raw Material-based Insights
Based on the raw material, the extracellular matrix market is segmented into bovine, porcine, and other raw materials. The porcine segment is expected to hold the largest share in the market, whereas, the bovine segment is expected to register the highest CAGR during the forecast period.
Based on the application, the extracellular matrix market has been segmented into soft tissue repair, dural repair , wound healing, cardiac repair, pericardial repair, and vascular repair and reconstruction. The soft tissue repair segment is likely to account for a larger market share in 2021. However, the vascular repair and reconstruction segment is expected to register a higher CAGR in the market during the forecast period.
Various companies operating in the extracellular matrix market are adopting marketing strategies, such as product launches, mergers and acquisitions, collaborations, product innovations, and product portfolio expansions to expand their footprint worldwide, maintain the brand name, and meet the increasing demand from end users.
Extracellular Matrix Market Report Scope
Company Profiles
- Anteris
- Aziyo Biologics, Inc
- Coloplast Group
- Cook Biotech, Inc
- DSM Biomedical
- Baxter
- Medtronic
- Merck KGaA
- MTF Biologics
- Smith & Nephew
Report Coverage
Revenue forecast, Company Analysis, Industry landscape, Growth factors, and Trends
Segment Covered
Raw Material and Application
Regional Scope
North America, Europe, Asia Pacific, Middle East & Africa, South & Central America
Country Scope
Argentina, Australia, Brazil, Canada, China, France, Germany, India, Italy, Japan, Mexico, Saudi Arabia, South Africa, South Korea, Spain, United Arab Emirates, United Kingdom, United States
Frequently Asked Questions
Global extracellular matrix market is segmented by region into North America, Europe, Asia Pacific, Middle East & Africa and South & Central America. In North America, the U.S. is the largest market for sleep apnea diagnostics. The market growth in the country is attributed to the rising prevalence of wounds and injuries. The growth of the market is mainly driven by the significant rise in cardiovascular disorders among the American population. And, Asia Pacific is the fastest-growing region growing at the CAGR of 8.2% during the forecast period.
The extracellular matrix market majorly consists of the players such as Anteris, Aziyo Biologics, Inc., Coloplast Group, Cook Biotech, Inc., DSM Biomedical, Baxter International, Inc., Medtronic, Merck KGaA, MTF Biologics, and Smith & Nephew, among others
The soft tissue repair segment dominated the global extracellular matrix market and accounted for the largest revenue share of 24.11% in 2021.
The Porcine segment dominated the global extracellular matrix market and held the largest revenue share of 43.76% in 2021.
Extracellular matrix is present in the outer side of the tissues and it helps tissues to bind the cells with collagen. It consists of structural proteins, glycoproteins, glycosaminoglycans and proteoglycans. Extracellular matrix enables recipient cells to regrow and thus it is used in various applications which include cardiac and vascular repair procedure.
Key factors that are driving the growth of this market are rising incidence of cardiovascular diseases and trauma along with increase in vascular reconstruction procedures.
1. Introduction
1.1 Scope of the Study
1.2 The Insight Partners Research Report Guidance
1.3 Market Segmentation
1.3.1 Global Extracellular Matrix Market – By Raw Material
1.3.2 Global Extracellular Matrix Market – By Application
1.3.3 Global Extracellular Matrix Market – By Geography
2. Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. Extracellular Matrix Market – Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 North America PEST Analysis
4.2.2 Europe PEST Analysis
4.2.3 Asia Pacific PEST Analysis
4.2.4 Middle East and Africa PEST Analysis
4.2.5 South and Central America PEST Analysis
4.3 Experts Opinion
5. Extracellular Matrix Market– Key Market Dynamics
5.1 Market Drivers
5.1.1 Significantly Rising Incidences of Trauma & Cardiovascular Diseases
5.1.2 Increasing Vascular Reconstruction Procedures
5.2 Market Restraints
5.2.1 Challenges During the Usage of Decellularized Extracellular Matrix
5.3 Market Opportunities
5.3.1 Growth Opportunities in the Developing Nations
5.4 Future Trends
5.4.1 Benefits of Treating Cancer
5.5 Impact Analysis
6. Extracellular Matrix Market– Global Analysis
6.1 Global Extracellular Matrix Market Revenue Forecast and Analysis
6.2 Global Extracellular Matrix Market Revenue Forecast and Analysis
6.3 Market Positioning of Key Players
7. Extracellular Matrix Market Revenue and Forecasts To 2028 – Raw Material
7.1 Overview
7.2 Global Extracellular Matrix Market Share by Raw Material - 2021 & 2028 (%)
7.3 Porcine
7.3.1 Overview
7.3.2 Porcine: Extracellular Matrix Market Revenue and Forecast to 2028 (US$ Thousand)
7.4 Bovine
7.4.1 Overview
7.4.2 Bovine: Extracellular Matrix Market Revenue and Forecast to 2028 (US$ Thousand)
7.5 Others
7.5.1 Overview
7.5.2 Others: Extracellular Matrix Market Revenue and Forecast to 2028 (US$ Thousand)
8. Extracellular Matrix Market Analysis – By Application
8.1 Overview
8.2 Global Extracellular Matrix Market, By Application, 2021 & 2028 (%)
8.4 Soft Tissue Repair
8.4.1 Overview
8.4.2 Soft Tissue Repair: Extracellular Matrix Market Revenue and Forecasts to 2028 (US$ Thousand)
8.5 Dural Repair
8.5.1 Overview
8.5.2 Dural Repair: Extracellular Matrix Market Revenue and Forecasts to 2028 (US$ Thousand)
8.6 Wound Healing
8.6.1 Overview
8.6.2 Wound Healing: Extracellular Matrix Market Revenue and Forecasts to 2028 (US$ Thousand)
8.7 Cardiac Repair
8.7.1 Overview
8.7.2 Cardiac Repair: Extracellular Matrix Market Revenue and Forecasts to 2028 (US$ Thousand)
8.8 Pericardial Repair
8.8.1 Overview
8.8.2 Pericardial Repair: Extracellular Matrix Market Revenue and Forecasts to 2028 (US$ Thousand)
8.10 Vascular Repair and Reconstruction
8.10.1 Overview
8.10.2 Vascular Repair and Reconstruction: Extracellular Matrix Market Revenue and Forecasts to 2028 (US$ Thousand)
9. Global Extracellular Matrix Market – Geographic Analysis
9.1 North America: Extracellular Matrix Market
9.1.1 Overview
9.1.2 North America: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
9.1.3 North America: Extracellular Matrix Market, by Raw Material, 2019–2028 (US$ Thousand)
9.1.4 North America: Extracellular Matrix Market, by Application, 2019–2028 (US$ Thousand)
9.1.5 North America: Extracellular Matrix Market, by Country, 2021 & 2028 (%)
9.1.5.1 US: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
9.1.5.1.1 US: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
9.1.5.1.2 US: Extracellular Matrix Market, by Raw Material, 2019–2028 (US$ Thousand)
9.1.5.1.3 US: Extracellular Matrix Market, by Application, 2019–2028 (US$ Thousand)
9.1.5.2 Canada: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
9.1.5.2.1 Canada: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
9.1.5.2.2 Canada: Extracellular Matrix Market, by Raw Material, 2019–2028 (US$ Thousand)
9.1.5.2.3 Canada: Extracellular Matrix Market, by Application, 2019–2028 (US$ Thousand)
9.1.6 Mexico: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
9.1.6.1 Mexico: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
9.1.6.2 Mexico: Extracellular Matrix Market, by Raw Material, 2019–2028 (US$ Thousand)
9.1.6.3 Mexico: Extracellular Matrix Market, by Application, 2019–2028 (US$ Thousand)
9.2 Europe: Extracellular Matrix Market Revenue and Forecasts to 2028
9.2.1 Overview
9.2.2 Europe: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
9.2.3 Europe: Extracellular Matrix Market, by Raw Material– Revenue and Forecast to 2028 (US$ Thousand)
9.2.4 Europe: Extracellular Matrix Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
9.2.5 Europe: Extracellular Matrix Market, by Country, 2021 & 2028 (%)
9.2.5.1 Germany: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
9.2.5.1.1 Germany: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
9.2.5.1.2 Germany: Extracellular Matrix Market, by Raw Material– Revenue and Forecast to 2028 (US$ Thousand)
9.2.5.1.3 Germany: Extracellular Matrix Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
9.2.5.2 France: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
9.2.5.2.1 France: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
9.2.5.2.2 France: Extracellular Matrix Market, by Raw Material– Revenue and Forecast to 2028 (US$ Thousand)
9.2.5.2.3 France: Extracellular Matrix Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
9.2.5.3 UK: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
9.2.5.3.1 UK: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
9.2.5.3.2 UK: Extracellular Matrix Market, by Raw Material– Revenue and Forecast to 2028 (US$ Thousand)
9.2.5.3.3 UK: Extracellular Matrix Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
9.2.5.4 Italy: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
9.2.5.4.1 Italy: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
9.2.5.4.2 Italy: Extracellular Matrix Market, by Raw Material– Revenue and Forecast to 2028 (US$ Thousand)
9.2.5.4.3 Italy: Extracellular Matrix Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
9.2.5.5 Spain: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
9.2.5.5.1 Spain: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
9.2.5.5.2 Spain: Extracellular Matrix Market, by Raw Material– Revenue and Forecast to 2028 (US$ Thousand)
9.2.5.5.3 Spain: Extracellular Matrix Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
9.2.5.6 Rest of Europe: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
9.2.5.6.1 Rest of Europe: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
9.2.5.6.2 Rest of Europe: Extracellular Matrix Market, by Raw Material– Revenue and Forecast to 2028 (US$ Thousand)
9.2.5.6.3 Rest of Europe: Extracellular Matrix Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
9.3 Asia Pacific: Extracellular Matrix Market
9.3.1 Overview
9.3.2 Asia Pacific: Extracellular Matrix Market - Revenue and Forecast to 2028 (US$ Thousand)
9.3.3 Asia Pacific: Extracellular Matrix Market, By Raw Material, 2019–2028 (US$ Thousand)
9.3.4 Asia Pacific: Extracellular Matrix Market, By Application, 2019–2028 (US$ Thousand)
9.3.5 Asia Pacific: Extracellular Matrix Market, by Country, 2021 & 2028 (%)
9.3.5.1 China: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
9.3.5.1.1 China: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
9.3.5.1.2 China: Extracellular Matrix Market, By Raw Material, 2019–2028 (US$ Thousand)
9.3.5.1.3 China: Extracellular Matrix Market, By Application, 2019–2028 (US$ Thousand)
9.3.5.2 Japan: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
9.3.5.2.1 Japan: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
9.3.5.2.2 Japan: Extracellular Matrix Market, By Raw Material, 2019–2028 (US$ Thousand)
9.3.5.2.3 Japan: Extracellular Matrix Market, By Application, 2019–2028 (US$ Thousand)
9.3.5.3 India: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
9.3.5.3.1 India: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
9.3.5.3.2 India: Extracellular Matrix Market, By Raw Material, 2019–2028 (US$ Thousand)
9.3.5.3.3 India: Extracellular Matrix Market, By Application, 2019–2028 (US$ Thousand)
9.3.5.4 Australia: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
9.3.5.4.1 Australia: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
9.3.5.4.2 Australia: Extracellular Matrix Market, By Raw Material, 2019–2028 (US$ Thousand)
9.3.5.4.3 Australia: Extracellular Matrix Market, By Application, 2019–2028 (US$ Thousand)
9.3.5.5 South Korea: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
9.3.5.5.1 South Korea: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
9.3.5.5.2 South Korea: Extracellular Matrix Market, By Raw Material, 2019–2028 (US$ Thousand)
9.3.5.5.3 South Korea: Extracellular Matrix Market, By Application, 2019–2028 (US$ Thousand)
9.3.5.6 Rest of Asia Pacific: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
9.3.5.6.1 Rest of Asia Pacific: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
9.3.5.6.2 Rest of Asia Pacific: Extracellular Matrix Market, By Raw Material, 2019–2028 (US$ Thousand)
9.3.5.6.3 Rest of Asia Pacific: Extracellular Matrix Market, By Application, 2019–2028 (US$ Thousand)
9.4 Middle East & Africa: Extracellular Matrix Market
9.4.1 Overview
9.4.2 Middle East & Africa: Extracellular Matrix Market - Revenue and Forecast to 2028 (US$ Thousand)
9.4.3 Middle East & Africa Extracellular Matrix Market, by Raw Material – Revenue and Forecast to 2028 (US$ Thousand)
9.4.4 Middle East & Africa Extracellular Matrix Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
9.4.5 Middle East & Africa: Extracellular Matrix Market, by Country, 2021 & 2028 (%)
9.4.5.1 Saudi Arabia: Extracellular Matrix Market - Revenue and Forecast to 2028 (US$ Thousand)
9.4.5.1.1 Saudi Arabia: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
9.4.5.1.2 Saudi Arabia Extracellular Matrix Market, by Raw Material – Revenue and Forecast to 2028 (US$ Thousand)
9.4.5.1.3 Saudi Arabia Extracellular Matrix Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
9.4.5.2 UAE: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
9.4.5.2.1 UAE: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
9.4.5.2.2 UAE Extracellular Matrix Market, by Raw Material – Revenue and Forecast to 2028 (US$ Thousand)
9.4.5.2.3 UAE Extracellular Matrix Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
9.4.5.3 South Africa: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
9.4.5.3.1 South Africa: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
9.4.5.3.2 South Africa Extracellular Matrix Market, by Raw Material – Revenue and Forecast to 2028 (US$ Thousand)
9.4.5.3.3 South Africa Extracellular Matrix Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
9.4.5.4 Rest of Middle East and Africa: Extracellular Matrix Market - Revenue and Forecast to 2028 (US$ Thousand)
9.4.5.4.1 Rest of Middle East and Africa: Extracellular Matrix Market - Revenue and Forecast to 2028 (US$ Thousand)
9.4.5.4.2 Rest of Middle East & Africa Extracellular Matrix Market, by Raw Material – Revenue and Forecast to 2028 (US$ Thousand)
9.4.5.4.3 Rest of Middle East & Africa Extracellular Matrix Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
9.5 South and Central America: Extracellular Matrix Market
9.5.1 Overview
9.5.2 South and Central America: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
9.5.3 South and Central America: Extracellular Matrix Market, by Raw Material– Revenue and Forecast to 2028 (US$ Thousand)
9.5.4 South and Central America: Extracellular Matrix Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
9.5.5 South and Central America: Extracellular Matrix Market, by Country, 2021 & 2028 (%)
9.5.5.1 Brazil: Extracellular Matrix Market - Revenue and Forecast to 2028 (US$ Thousand)
9.5.5.1.1 Brazil: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
9.5.5.1.2 Brazil: Extracellular Matrix Market, by Raw Material– Revenue and Forecast to 2028 (US$ Thousand)
9.5.5.1.3 Brazil: Extracellular Matrix Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
9.5.5.2 Argentina: Extracellular Matrix Market - Revenue and Forecast to 2028 (US$ Thousand)
9.5.5.2.1 Argentina: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
9.5.5.2.3 Argentina: Extracellular Matrix Market, by Raw Material– Revenue and Forecast to 2028 (US$ Thousand)
9.5.5.2.4 Argentina: Extracellular Matrix Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
9.5.5.3 Rest of South and Central America: Extracellular Matrix Market - Revenue and Forecast to 2028 (US$ Thousand)
9.5.5.3.1 Rest of South and Central America: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
9.5.5.3.2 Rest of South and Central America: Extracellular Matrix Market, by Raw Material– Revenue and Forecast to 2028 (US$ Thousand)
9.5.5.3.3 Rest of South and Central America: Extracellular Matrix Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
10. Impact of COVID-19 Pandemic on Global Extracellular Matrix Market
10.1 North America: Impact Assessment of COVID-19 Pandemic
10.2 Europe: Impact Assessment of COVID-19 Pandemic
10.3 Asia-Pacific: Impact Assessment of COVID-19 Pandemic
10.4 Middle East and Africa: Impact Assessment of COVID-19 Pandemic
10.5 South and Central America: Impact Assessment of COVID-19 Pandemic
11. Industry Landscape
11.1 Overview
11.2 Growth Strategies in the Extracellular Matrix Market
11.3 Organic Developments
11.3.1 Overview
11.4 Inorganic Developments
11.4.1 Overview
12. Company Profiles
12.1 Medtronic
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 MERCK KGaA
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 MTF Biologics
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Smith & Nephew
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Anteris
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Aziyo
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Coloplast Group
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Baxter
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 DSM
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
12.10 Cook Biotech Inc.
12.10.1 Key Facts
12.10.2 Business Description
12.10.3 Products and Services
12.10.4 Financial Overview
12.10.5 SWOT Analysis
12.10.6 Key Developments
13. Appendix
13.1 About The Insight Partners
13.2 Glossary of Terms
LIST OF TABLES
Table 1. North America Extracellular Matrix Market, by Raw Material– Revenue and Forecast to 2028 (US$ Thousand)
Table 2. North America Extracellular Matrix Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 3. US: Extracellular Matrix Market, by Raw Material– Revenue and Forecast to 2028 (US$ Thousand)
Table 4. US Extracellular Matrix Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 5. Canada Extracellular Matrix Market, by Raw Material– Revenue and Forecast to 2028 (US$ Thousand)
Table 6. Canada: Extracellular Matrix Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 7. Mexico Extracellular Matrix Market, by Raw Material– Revenue and Forecast to 2028 (US$ Thousand)
Table 8. Mexico: Extracellular Matrix Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 9. Europe: Extracellular Matrix Market, by Raw Material– Revenue and Forecast to 2028 (US$ Thousand)
Table 10. Europe: Extracellular Matrix Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 11. Germany: Extracellular Matrix Market, by Raw Material– Revenue and Forecast to 2028 (US$ Thousand)
Table 12. Germany: Extracellular Matrix Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 13. France: Extracellular Matrix Market, by Raw Material– Revenue and Forecast to 2028 (US$ Thousand)
Table 14. France: Extracellular Matrix Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 15. UK: Extracellular Matrix Market, by Raw Material– Revenue and Forecast to 2028 (US$ Thousand)
Table 16. UK: Extracellular Matrix Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 17. Italy: Extracellular Matrix Market, by Raw Material– Revenue and Forecast to 2028 (US$ Thousand)
Table 18. Italy: Extracellular Matrix Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 19. Spain: Extracellular Matrix Market, by Raw Material– Revenue and Forecast to 2028 (US$ Thousand)
Table 20. Spain: Extracellular Matrix Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 21. Rest of Europe: Extracellular Matrix Market, by Raw Material– Revenue and Forecast to 2028 (US$ Thousand)
Table 22. Rest of Europe: Extracellular Matrix Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 23. Asia Pacific: Extracellular Matrix Market, By Raw Material – Revenue and Forecast to 2028 (US$ Thousand)
Table 24. Asia Pacific: Extracellular Matrix Market, By Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 25. China: Extracellular Matrix Market, By Raw Material – Revenue and Forecast to 2028 (US$ Thousand)
Table 26. China: Extracellular Matrix Market, By Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 27. Japan: Extracellular Matrix Market, By Raw Material – Revenue and Forecast to 2028 (US$ Thousand)
Table 28. Japan: Extracellular Matrix Market, By Application– Revenue and Forecast to 2028 (US$ Thousand)
Table 29. India: Extracellular Matrix Market, By Raw Material– Revenue and Forecast to 2028 (US$ Thousand)
Table 30. India: Extracellular Matrix Market, By Application– Revenue and Forecast to 2028 (US$ Thousand)
Table 31. Australia: Extracellular Matrix Market, By Raw Material – Revenue and Forecast to 2028 (US$ Thousand)
Table 32. Australia: Extracellular Matrix Market, By Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 33. South Korea: Extracellular Matrix Market, By Raw Material – Revenue and Forecast to 2028 (US$ Thousand)
Table 34. South Korea: Extracellular Matrix Market, By Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 35. Rest of Asia Pacific: Extracellular Matrix Market, By Raw Material – Revenue and Forecast to 2028 (US$ Thousand)
Table 36. Rest of Asia Pacific: Extracellular Matrix Market, By Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 37. Middle East & Africa Extracellular Matrix Market, by Raw Material – Revenue and Forecast to 2028 (US$ Thousand)
Table 38. Middle East & Africa Extracellular Matrix Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 39. Saudi Arabia Extracellular Matrix Market, by Raw Material – Revenue and Forecast to 2028 (US$ Thousand)
Table 40. Saudi Arabia Extracellular Matrix Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 41. UAE Extracellular Matrix Market, by Raw Material – Revenue and Forecast to 2028 (US$ Thousand)
Table 42. UAE Extracellular Matrix Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 43. South Africa Extracellular Matrix Market, by Raw Material – Revenue and Forecast to 2028 (US$ Thousand)
Table 44. South Africa Extracellular Matrix Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 45. Rest of Middle East & Africa Extracellular Matrix Market, by Raw Material – Revenue and Forecast to 2028 (US$ Thousand)
Table 46. Rest of Middle East & Africa Extracellular Matrix Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 47. South and Central America: Extracellular Matrix Market, by Raw Material– Revenue and Forecast to 2028 (US$ Thousand)
Table 48. South and Central America: Extracellular Matrix Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 49. Brazil: Extracellular Matrix Market, by Raw Material– Revenue and Forecast to 2028 (US$ Thousand)
Table 50. Brazil: Extracellular Matrix Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 51. Argentina: Extracellular Matrix Market, by Raw Material– Revenue and Forecast to 2028 (US$ Thousand)
Table 52. Argentina: Extracellular Matrix Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 53. Rest Of South And Central America: Extracellular Matrix Market, by Raw Material– Revenue and Forecast to 2028 (US$ Thousand)
Table 54. Rest Of South And Central America: Extracellular Matrix Market, by Application – Revenue and Forecast to 2028 (US$ Thousand)
Table 55. Organic Developments Done By Companies
Table 56. Inorganic Developments Done By Companies
Table 57. Glossary of Terms, Extracellular Matrix Market
LIST OF FIGURES
Figure 1. Extracellular Matrix Market Segmentation
Figure 2. Extracellular Matrix Market, By Region
Figure 3. Global Extracellular Matrix Market Overview
Figure 4. Porcine Segment Held Largest Share by Raw Material Segment in Extracellular Matrix Market
Figure 5. Asia Pacific is Expected to Show Remarkable Growth During the Forecast Period
Figure 6. Extracellular Matrix Market, by Geography (US$ Thousand)
Figure 7. Global Extracellular Matrix Market- Leading Country Markets (US$ Thousand)
Figure 8. Global Extracellular Matrix Market, Industry Landscape
Figure 9. North America: PEST Analysis
Figure 10. Europe: PEST Analysis
Figure 11. Asia Pacific: PEST Analysis
Figure 12. Middle East And Africa: PEST Analysis
Figure 13. South And Central America: PEST Analysis
Figure 14. Experts Opinion
Figure 15. Impact Analysis of Drivers and Restraints Pertaining to Extracellular Matrix Market
Figure 16. Global Extracellular Matrix Market– Revenue Forecast and Analysis – 2020- 2028
Figure 17. Global Extracellular Matrix Market– Revenue Forecast and Analysis – 2021 - 2028
Figure 18. Market Positioning of Key Players in Global Extracellular Matrix Market
Figure 19. Global Extracellular Matrix Market Share by Raw Material - 2021 & 2028 (%)
Figure 20. Porcine: Extracellular Matrix Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 21. Bovine: Extracellular Matrix Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 22. Others: Extracellular Matrix Market Revenue and Forecasts To 2028 (US$ Thousand)
Figure 23. Global Extracellular Matrix Market, By Application, 2021 & 2028 (%)
Figure 24. Soft Tissue Repair: Extracellular Matrix Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 25. Dural Repair: Extracellular Matrix Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 26. Wound Healing: Extracellular Matrix Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 27. Cardiac Repair: Extracellular Matrix Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 28. Pericardial Repair: Extracellular Matrix Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 29. Vascular Repair and Reconstruction: Extracellular Matrix Market Revenue and Forecasts to 2028 (US$ Thousand)
Figure 30. North America: Extracellular Matrix Market, by Key Country – Revenue (2021) (US$ Thousand)
Figure 31. North America Extracellular Matrix Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 32. North America: Extracellular Matrix Market, by Country, 2021 & 2028 (%)
Figure 33. US: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 34. Canada: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 35. Mexico: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 36. Europe: Extracellular Matrix Market, by Key Country – Revenue (2021) (US$ Thousand)
Figure 37. Europe: Extracellular Matrix Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 38. Europe: Extracellular Matrix Market, by Country, 2021 & 2028 (%)
Figure 39. Germany: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 40. France: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 41. UK: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 42. Italy: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 43. Spain: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 44. Rest of Europe: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 45. Asia Pacific: Extracellular Matrix Market, by Key Country – Revenue (2021) (US$ Thousand)
Figure 46. Asia Pacific Extracellular Matrix Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 47. Asia Pacific: Extracellular Matrix Market, by Country, 2021 & 2028 (%)
Figure 48. China: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 49. Japan: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 50. India: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)...
Figure 51. Australia: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 52. South Korea: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 53. Rest of Asia Pacific: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 54. Middle East & Africa: Extracellular Matrix Market, by Key Country – Revenue (2021) (US$ Thousand)
Figure 55. Middle East & Africa Extracellular Matrix Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 56. Middle East & Africa: Extracellular Matrix Market, by Country, 2021 & 2028 (%)
Figure 57. Saudi Arabia: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 58. UAE: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)....
Figure 59. South Africa: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 60. Rest of Middle East and Africa: Extracellular Matrix Market - Revenue and Forecast to 2028 (US$ Thousand)
Figure 61. South and Central America: Extracellular Matrix Market, by Key Country – Revenue (2021) (US$ Thousand)
Figure 62. South and Central America: Extracellular Matrix Market Revenue and Forecast to 2028 (US$ Thousand)
Figure 63. South and Central America: Extracellular Matrix Market, by Country, 2021 & 2028 (%)
Figure 64. Brazil: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)..
Figure 65. Argentina: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 66. Rest Of South And Central America: Extracellular Matrix Market – Revenue and Forecast to 2028 (US$ Thousand)
Figure 67. Impact of COVID-19 Pandemic in North American Country Markets
Figure 68. Impact of COVID-19 Pandemic in European Country Markets
Figure 69. Impact of COVID-19 Pandemic in Asia Pacific Country Markets
Figure 70. Impact Of COVID-19 Pandemic in Middle East and Africa Country Markets
Figure 71. Impact of COVID-19 Pandemic in the South and Central America Country Markets
Figure 72. Growth Strategies in the Extracellular Matrix Market
The List of Companies - Extracellular Matrix Market
- Anteris
- Aziyo Biologics, Inc
- Coloplast Group
- Cook Biotech, Inc
- DSM Biomedical
- Baxter
- Medtronic
- Merck KGaA
- MTF Biologics
- Smith & Nephew
The Insight Partners performs research in 4 major stages: Data Collection & Secondary Research, Primary Research, Data Analysis and Data Triangulation & Final Review.
- Data Collection and Secondary Research:
As a market research and consulting firm operating from a decade, we have published many reports and advised several clients across the globe. First step for any study will start with an assessment of currently available data and insights from existing reports. Further, historical and current market information is collected from Investor Presentations, Annual Reports, SEC Filings, etc., and other information related to company’s performance and market positioning are gathered from Paid Databases (Factiva, Hoovers, and Reuters) and various other publications available in public domain.
Several associations trade associates, technical forums, institutes, societies and organizations are accessed to gain technical as well as market related insights through their publications such as research papers, blogs and press releases related to the studies are referred to get cues about the market. Further, white papers, journals, magazines, and other news articles published in the last 3 years are scrutinized and analyzed to understand the current market trends.
- Primary Research:
The primarily interview analysis comprise of data obtained from industry participants interview and answers to survey questions gathered by in-house primary team.
For primary research, interviews are conducted with industry experts/CEOs/Marketing Managers/Sales Managers/VPs/Subject Matter Experts from both demand and supply side to get a 360-degree view of the market. The primary team conducts several interviews based on the complexity of the markets to understand the various market trends and dynamics which makes research more credible and precise.
A typical research interview fulfils the following functions:
- Provides first-hand information on the market size, market trends, growth trends, competitive landscape, and outlook
- Validates and strengthens in-house secondary research findings
- Develops the analysis team’s expertise and market understanding
Primary research involves email interactions and telephone interviews for each market, category, segment, and sub-segment across geographies. The participants who typically take part in such a process include, but are not limited to:
- Industry participants: VPs, business development managers, market intelligence managers and national sales managers
- Outside experts: Valuation experts, research analysts and key opinion leaders specializing in the electronics and semiconductor industry.
Below is the breakup of our primary respondents by company, designation, and region:
Once we receive the confirmation from primary research sources or primary respondents, we finalize the base year market estimation and forecast the data as per the macroeconomic and microeconomic factors assessed during data collection.
- Data Analysis:
Once data is validated through both secondary as well as primary respondents, we finalize the market estimations by hypothesis formulation and factor analysis at regional and country level.
- 3.1 Macro-Economic Factor Analysis:
We analyse macroeconomic indicators such the gross domestic product (GDP), increase in the demand for goods and services across industries, technological advancement, regional economic growth, governmental policies, the influence of COVID-19, PEST analysis, and other aspects. This analysis aids in setting benchmarks for various nations/regions and approximating market splits. Additionally, the general trend of the aforementioned components aid in determining the market's development possibilities.
- 3.2 Country Level Data:
Various factors that are especially aligned to the country are taken into account to determine the market size for a certain area and country, including the presence of vendors, such as headquarters and offices, the country's GDP, demand patterns, and industry growth. To comprehend the market dynamics for the nation, a number of growth variables, inhibitors, application areas, and current market trends are researched. The aforementioned elements aid in determining the country's overall market's growth potential.
- 3.3 Company Profile:
The “Table of Contents” is formulated by listing and analyzing more than 25 - 30 companies operating in the market ecosystem across geographies. However, we profile only 10 companies as a standard practice in our syndicate reports. These 10 companies comprise leading, emerging, and regional players. Nonetheless, our analysis is not restricted to the 10 listed companies, we also analyze other companies present in the market to develop a holistic view and understand the prevailing trends. The “Company Profiles” section in the report covers key facts, business description, products & services, financial information, SWOT analysis, and key developments. The financial information presented is extracted from the annual reports and official documents of the publicly listed companies. Upon collecting the information for the sections of respective companies, we verify them via various primary sources and then compile the data in respective company profiles. The company level information helps us in deriving the base number as well as in forecasting the market size.
- 3.4 Developing Base Number:
Aggregation of sales statistics (2020-2022) and macro-economic factor, and other secondary and primary research insights are utilized to arrive at base number and related market shares for 2022. The data gaps are identified in this step and relevant market data is analyzed, collected from paid primary interviews or databases. On finalizing the base year market size, forecasts are developed on the basis of macro-economic, industry and market growth factors and company level analysis.
- Data Triangulation and Final Review:
The market findings and base year market size calculations are validated from supply as well as demand side. Demand side validations are based on macro-economic factor analysis and benchmarks for respective regions and countries. In case of supply side validations, revenues of major companies are estimated (in case not available) based on industry benchmark, approximate number of employees, product portfolio, and primary interviews revenues are gathered. Further revenue from target product/service segment is assessed to avoid overshooting of market statistics. In case of heavy deviations between supply and demand side values, all thes steps are repeated to achieve synchronization.
We follow an iterative model, wherein we share our research findings with Subject Matter Experts (SME’s) and Key Opinion Leaders (KOLs) until consensus view of the market is not formulated – this model negates any drastic deviation in the opinions of experts. Only validated and universally acceptable research findings are quoted in our reports.
We have important check points that we use to validate our research findings – which we call – data triangulation, where we validate the information, we generate from secondary sources with primary interviews and then we re-validate with our internal data bases and Subject matter experts. This comprehensive model enables us to deliver high quality, reliable data in shortest possible time.
Trends and growth analysis reports related to Extracellular Matrix Market
Dec 2021
Laser-Assisted ENT Surgeries Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Laser Type (C02 Laser, Nd:YAG Laser, Diode Laser, Blue Laser, KTP Laser, Argon Laser, and Other Laser Types), Surgery Type [Laser Laryngeal Surgery, Laser Endoscopic Sinus Surgery (LESS), Laser-Assisted Uvulopalatoplasty (LAUP), Laser-Assisted Stapedotomy, Laser-Assisted Tonsillectomy and Adenoidectomy, Laser Turbinates Reduction, Transoral Laser Microsurgery (TLM), Nasal Surgery, and Other Surgery Types], End User (Hospitals and Specialty Clinics, Physician Offices, and Other End Users), and Geography (North America, Europe, Asia Pacific, South and Central America, and Middle East and Africa)
Dec 2021
Mobile Cleanroom Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Softwall and Hardwall), End User (Microelectronics Industry, Pharmaceuticals and Biotechnology Industry, Medical Device Manufacturers, and Others), and Geography
Dec 2021
Ovo-Sexing Technology Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Technique (Non-Invasive Imaging, Genetic Editing, Volatile Analysis, Sex Reversal, and Liquid-Based Analysis), End User (Hatcheries and Poultry Farms), and Geography (US, Germany, France, Italy, Spain, Rest of Europe, Israel, and ROW)
Dec 2021
Dental Laser Treatment Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Hard Tissue, Soft Tissue, and Others), End User (Hospitals, Dental Clinics, Dental-Owned Practices, and Others), Clinical Indication [Conservative Dentistry, Root Canal (Endodontic Treatment), Oral Surgery, Implantology, Peri-Implantitis, Periodontics, and Others], and Geography
Dec 2021
Microbiology CRO Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Application (Clinical, Medical Device, and Others), Service Type (Assay Development, Custom Viral Stock Production, Microbial Testing, and Others), Microorganisms (Bacteria, Fungi, Viruses, and Parasites), End User (Biotech and Pharmaceutical Companies, Medical Device Companies, and Others), and Geography
Dec 2021
Antimicrobial Surgical Suture Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Triclosan Antimicrobial Suture and Chlorhexidine Antimicrobial Suture), Raw Materials (Polyglactin 910 Antimicrobial Suture, Poliglecaprone 25, and Polyglycolic Acid), Application (Cardiovascular Surgery, General Surgery, Ophthalmic Surgery, Gynecological Surgery, Orthopedic Surgery, Plastic Surgery, Veterinary Surgery, Dental Surgery, and Others), End User (Hospitals, Ambulatory Surgical Centers, and Others), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Dec 2021
Fall Management Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Product (Sensor Pads, Floor Mat, Hip Protectors, Alert Systems, Communication Devices, and Other Products), Application (Fall Detection Systems, Fall Prevention Equipment, and Post-Fall Monitoring and Response Systems), Age Group [Elderly Population (65 and Above) and Adults (18–64 years)], End User (Hospitals and Clinics, Nursing Homes, Home Care Settings, and Other End Users), and Geography
Dec 2021
Organoids Services Market
Size and Forecast (2021 - 2031), Global and Regional Share, Trend, and Growth Opportunity Analysis Report Coverage: By Type (Intestine, Liver, Stomach, Pancreas, Lung, Brain, Kidney, and Others), Application (Developmental Biology Disease, Pathology of Infectious Disease, Regenerative Medicine, Drug Toxicity & Efficacy Testing, Drug Discovery & Personalized Medicine, and Others), Source (Pluripotent Stem Cells and Organ Specific Adult Stem Cell), and Geography (North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America)
Get Free Sample For